Venture Capital Deals and Investments
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Venture Capital Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
Pelage Pharmaceuticals Raises $120M in Series B Co-Led by ARCH and GV
Series BVenture Capital

Pelage Pharmaceuticals Raises $120M in Series B Co-Led by ARCH and GV

•October 15, 2025
•Oct 15, 2025
0

Participants

Pelage

Pelage

company

ARCH Venture Partners

ARCH Venture Partners

investor

GV

GV

investor

Main Street Advisors

Main Street Advisors

investor

Visionary Ventures

Visionary Ventures

investor

Deal Summary

Pelage Pharmaceuticals closed a $120 million Series B to advance its lead topical program PP405 for hair follicle stem cell reactivation. The round was co-led by ARCH Venture Partners and GV, with participation from Main Street Advisors, Visionary Ventures, and YK Bioventures.

0

Comments

Want to join the conversation?

Loading comments...